What top creators are saying about Rocket Lab USA, Inc.(RKLB)

High-beta name showing a weak technical setup; patience suggested for building positions into late 2024.

Chosen as a growth asset for a portfolio spanning until mid-2027.

Selected for long-term viability assessment in a concentrated portfolio.

Strong technical trade basing at the 50-day EMA; viewed as a top SpaceX-related proxy.

Identified as a weaker stock to short or hedge against in a rising rate environment.

Holding support at 99-100; a bounce is possible if levels hold, though low 80s offer a better entry.

Saw a brutal trade where it plummeted after being added to the NASDAQ 100 on the SpaceX IPO day.

Bearish sentiment as capital rotates out of 'retail proxies' now that SpaceX is tradable.

Stock fell 10% as the SpaceX IPO acted as a liquidity vacuum, failing as a proxy trade.

Experienced a 'sell the news' double-digit drop following the SpaceX IPO.

Analyst believes it is too late to enter this proxy trade following the SpaceX IPO hype.

Identified as a short opportunity at $122.30 due to potential capital rotation toward SpaceX

Suggested short position as a hedge against a potential SpaceX IPO, expecting capital outflows to the sector leader.

Anticipates a price drop into the $70s following a 10% decline on the SPCX IPO day and broader market concerns.

Risk of capital being sucked away by the SpaceX IPO despite recent gains.

Trading as a sympathy play ahead of the anticipated SpaceX IPO.

Identified as a 'space beta' that could see capital outflows due to the SpaceX IPO.

Receiving a sympathy bid from SpaceX IPO anticipation, but faces high volatility risk.

Valuation is considered 'absolute nosebleed' at 64x forward revenue and driven by hype rather than fundamentals.

Gaining momentum as part of the broader 'Space Economy' theme.

Significant price retrace; speculation that the space sector pump may have peaked for now.

Part of a future 'mega-bubble' but cautioned due to a recent 2x price move.

Viewed as a retail-driven 'chase' trade; speakers exited due to overvaluation after a contract win.

Sector sell-off following Blue Origin launch failure and SpaceX valuation rumors.

Expected to benefit from increased liquidity and interest in the space sector driven by SpaceX's potential IPO.

Entering a consolidation phase after a massive run; saw double-digit red days.

Stock hit by negative sentiment from Blue Origin explosion and SpaceX valuation rumors.

Seeing re-ratings as it provides essential infrastructure and launch capabilities for orbital access.

Surging manufacturing strength as a subcontractor for major space players and approaching its 100th Electron launch.

Sector-wide selling pressure following a Blue Origin launch failure, though SpaceX IPO remains a catalyst.

Long-term conviction play benefiting from lower launch costs and a major thematic trend in space technology.

Holding steady as a major theme in the emerging space narrative.

Benefiting from policy-driven momentum and increased demand for autonomous warfare hardware.

Showing continued retail and institutional interest as it hits key price levels in the space sector.

Highlighted as a 'monster' performer in the space sector, outperforming even some chip stocks.

Viewed as a more established and safer player in the space sector compared to micro-caps.

Benefiting from a 'halo effect' from the SpaceX IPO and approaching profitability milestones for potential index inclusion.

Increasingly viewed as a public proxy for SpaceX amid massive inflows into the space sector.

Massive momentum following a $90 million Space Force deal and sector tailwinds from the SpaceX IPO.

Primary way to play the space industry; momentum play that could go vertical.

The dominant public 'Space' play; currently seeing vertical momentum, though analysts suggest taking profits if the vertical move continues.

Experienced a sharp drop; analyst looking for consolidation at lower levels following 'stupid' highs.

Strong momentum leader in space growth, though trading on narrative rather than current profitability.

High euphoria as a SpaceX proxy; parabolic move suggests it may be time to take profits rather than buy.

Identified as a proxy stock experiencing upward momentum ahead of the SpaceX IPO event.

Considered the clear second-best in the space industry; a strategic play on the space narrative before potential SpaceX IPO hype.

Significant weekly gains amid strong momentum.

Experiencing continued gap-up momentum, rising 5.6%.

Trading as a public proxy for SpaceX with strong momentum and progress on the Neutron rocket.

Hit price targets at $120; analyst suggests profit taking as it hits resistance.